| Position | Action |
|---|---|
| Current position | Reduce 50-60% |
| Post-trim residual | Retain 40-50% position |
| Hard stop on close | $171 |
| Two-session breakdown below 10 EMA on above-average volume | Tighten stop to $178 |
| Elevated IV into binary event | Skip put hedge (reduction itself is the hedge) |
Salesforce is a category-leading, cash-gushing AI-platform franchise with re-accelerating revenue growth trading at a 12x forward P/E that has just executed a $27B buyback signaling massive insider confidence at a generational entry point.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $177.94 | bullish |
| 50 SMA | $171.01 | bullish |
| 200 SMA | $203.91 | bearish |
| RSI (14) | 60.98 | bullish |
| MACD (12,26,9) | +4.28 | bullish |
| Bollinger Upper Band | $188.85 | — |
| Bollinger Middle Band (20 SMA) | $171.64 | — |
| Bollinger Lower Band | $154.43 | — |
| ATR (14) | $8.47 | — |
| VWMA | $174.08 | bullish |
Support: 177.94 · 171.01 · 154.43 · 150.12 | Resistance: 188.85 · 193.7 · 200 · 203.91
CRM is in a technical transition zone—short-term and medium-term trends have flipped bullish (price above 10 EMA and 50 SMA, MACD positively crossed, RSI climbing from oversold 29.97 to 60.98), but the long-term 200 SMA at $203.91 continues to decline overhead with price sitting ~8.8% below it. The stock has recovered ~$35.83 (~23.9%) from the June 22 cycle low of $150.12, but current levels near the Bollinger Upper Band ($188.85) suggest some short-term extension risk. Key resistance at $193.70 intraday high and $200 psychological level must be cleared convincingly to confirm a new bull trend; the $171 confluence zone (50 SMA + Bollinger middle) is the critical support pivot. ATR expanding to $8.47 indicates a rising volatility regime requiring wider position stops.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Underweight: Reduce 50-60% at $188-192, Hold Residual 40-50% with Hard Stop at $171 Ahead of Binary Q2 FY27 Catalyst
The bear case is quantitatively dominant: deferred revenue declined 16% sequentially ($24.32B to $20.36B in Q1 FY27), the 200 SMA at $203.91 has rejected price for 11 consecutive months, goodwill at 56% of assets ($59.29B) carries impairment risk, and net debt quadrupled from $7B to $30.35B in one quarter as management financed a $27.25B buyback at implied average prices well above today's $185.95. However, the franchise's $16.55B TTM FCF and 77% gross margin justify retaining a residual 40-50% position rather than a full exit. The 50-60% reduction captures asymmetric risk-reward: large enough to be defensive ahead of the binary catalyst, small enough to participate if Q2 FY27 surprises positively or a breakout above $200 confirms on volume.
When: Q2 FY27 earnings beat with sequential deferred revenue stabilization and reaffirmed forward EPS guidance
Then: Re-enter
Revenue growth has re-accelerated to 12-13%, reversing the bear's thesis of structural decline to ~9%
↩ rebuts: “Bear thesis requires ~9% growth from mid-2025 to be the new normal, but the data shows re-acceleration to double-digit-plus growth”
· concedes: Price is below the 200 SMA at $203.91 (lagging indicator, but valid bearish signal on longer timeframes); Net debt did quadruple from $7.1B to $30.4B; Bear case for AI cannibalization has some merit and requires ongoing monitoring of competitive dynamics
CRM's risk/reward is tilted negative at $185.95: the honest framing is ~7.5% upside to $200 versus ~21% downside to the $146-150 zone, a 1:3 risk/reward that contradicts the bull's "asymmetric" thesis.
· concedes: CRM is a fundamentally good company; The franchise generates enormous cash; The macro setup has some bullish elements; The $1.6B VA contract is incremental revenue; The 12x forward P/E is a mature-utility multiple reflecting skepticism, not necessarily fair value
→ vs conservative: The 49% DCF undervaluation is meaningless if the inputs are wrong, and the 16% sequential decline in deferred revenue suggests the earnings growth assumptions underpinning the DCF model are flawed
→ vs conservative: The 100% upside projection and Cramer endorsement are lagging indicators of hope, not leading indicators of fundamental change; Cramer endorsements historically mark local tops rather than bottoms
→ vs neutral: The software rotation into beaten-down names is exactly the conditions that produce euphoric tops, not sustainable value re-rating; the bullish options data simply reflects wide dispersion, not directional conviction
Market Cap
$152.29B
P/E Ratio (TTM)
21.55x
Forward P/E
11.99x
PEG Ratio
0.76
Price / Book
4.45x
EV / Revenue (TTM)
~4.2x
Beta
1.152
52-Week High
$269.11
52-Week Low
$146.32
50-Day MA
$171.03
200-Day MA
$205.05
Dividend Yield
0.96%
Revenue (TTM)
$42.83B
Revenue Growth (Q1 FY27)
~13% YoY
EPS (TTM)
$8.63
Forward EPS
$15.51
EPS (Q1 FY27)
$2.42
Gross Margin
77.6%
Operating Margin
21.8%
Net Margin
18.7%
ROE
16.9%
ROA
5.7%
FCF (TTM)
$16.55B
FCF Margin (TTM)
38.6%
Cash & ST Investments
$11.84B
Total Debt
$41.88B
Net Debt
$30.35B
Debt/Equity
1.22x
Current Ratio
0.79
Goodwill
$59.29B
Deferred Revenue
$20.36B
Accounts Receivable
$5.08B
OCF TTM
~$15.2B
CapEx TTM
~$0.6B
Buybacks TTM
~$37B
Q1 FY27 Buyback
$27.25B
Q1 FY27 Debt Issuance
$24.84B
Diluted Shares (Apr'26)
871M
Diluted Shares (Jan'26)
940M
Strengths
Concerns
Salesforce (CRM) is a mega-cap ($152.3B) enterprise cloud software leader with a category-defining CRM franchise offering Sales Cloud, Service Cloud, Marketing Cloud, Slack, Tableau, MuleSoft, and AI/Agentforce capabilities. The company operates with best-in-class SaaS economics: 77.6% gross margins, 21.8% operating margins, and 38.6% FCF margins generating ~$16.55B in annual free cash flow. Revenue growth has re-accelerated from ~9% to ~13% YoY, with TTM revenue of $42.83B and EPS of $8.63 (forward EPS projected at $15.51). The major capital structure development is a historic $27.25B accelerated share repurchase in Q1 FY27 funded by $24.84B in new long-term debt, which reduced diluted shares from 940M to 871M but quadrupled net debt to $30.35B and raised the Debt/Equity ratio from 0.29x to 1.22x. Despite near-52-week low valuations (Forward P/E 12.0x, P/B 4.45x) and improving fundamentals, the stock faces bearish technicals (price below both 50-day and 200-day moving averages) and elevated leverage risk that requires careful monitoring.